A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET)
Trial details
- Registry ID
- NCT05122650
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET)NCT05122650 | Jazz Pharmaceuticals | Phase 2 | Completed | 2024-05-30Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |